However, different from previous studies on correlation between loss of p16 gene expression and tumor progression,[36,37] and p16INK4a overexpression in different grades of urothelial carcinomas,[33,37–39] our study showed no significant relationship between p16INK4a expression and the patient survival. The gene discussed is CDKN2A; the disease is urothelial carcinoma.